Indian pharma stocks rallied after US President Trump imposed sweeping tariffs but exempted the sector. The Nifty Pharma ...
GIFT Nifty signals a sharp 300-point drop, indicating a weak market opening. Global trade war concerns, FII selling, and ...
The tremors were felt in parts of the region, but there were no immediate reports of casualties or damage to property.
US President Trump announced a 26% reciprocal tariff on India, citing high trade barriers. The move shakes global markets, ...
Indian equities after the much-awaited tariff announcement opened lower in trade on April 3, 2025 (Thursday) reacting ...
Other automakers like Hyundai Motor India, Tata Motors, Mahindra and Mahindra, and Kia India already announced last month ...
Even though there is a belief that Trump may defer the impact of reciprocal tariffs, India being among few of the countries ...
In conversation with Zee Business, the market expert has suggested buying largecap and midcap stocks for a different ...
The Department of Commerce on Thursday said that it is also studying the opportunities that may arise due to this new ...
Analysts' stock recommendation list spread across various categories, including fundamental, technical, and cash segments.
As of the December quarter, Rakesh Jhunjhunwala's holding in the stock is at 49.3 per cent or 84,668,326 outstanding equity ...
Poonam Gupta’s appointment comes days ahead of the upcoming meeting of the RBI’s Monetary Policy Committee (MPC), scheduled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results